Tiglaz M Tablet is a diabetes medication containing Glibenclamide and Metformin to help control blood sugar levels.

Out of stock

SKU: 70560 Categories: ,


Product Description: Tiglaz M Tablet

Tiglaz M Tablet is a combination medication that contains Glibenclamide and Metformin as active ingredients. This tablet is specifically designed to treat type 2 diabetes mellitus. It helps control blood sugar levels by reducing insulin resistance and promoting the secretion of insulin.

– Glibenclamide: 5 mg
– Metformin: 500 mg

Tiglaz M Tablet is used to manage high blood sugar levels in individuals with type 2 diabetes mellitus. It is commonly prescribed to improve glycemic control when diet and exercise alone are insufficient. This medication can also be utilized as part of a combination therapy with insulin or other oral antidiabetic drugs.

Ailments in which Tiglaz M Tablet is used:
– Type 2 diabetes mellitus

Mechanism of Action:
Glibenclamide, a sulfonylurea, stimulates the pancreas to release insulin, thereby increasing insulin secretion. This action helps reduce blood sugar levels. It also enhances the uptake of glucose by the peripheral tissues, including skeletal muscles, adipose tissue, and the liver.

Metformin, a biguanide, enhances the sensitivity of the peripheral tissues to insulin, allowing glucose to enter the cells more efficiently. It also reduces the production of glucose in the liver. Additionally, Metformin helps lower blood sugar levels by increasing glucose utilization in the muscles.

Tiglaz M Tablet is a combination medication used in the treatment of type 2 diabetes mellitus. It contains Glibenclamide and Metformin, which work together to improve glycemic control by reducing insulin resistance and enhancing insulin secretion. This tablet is prescribed to individuals who have not successfully managed their diabetes with diet and exercise alone. As always, it is important to consult with a healthcare professional before starting or changing any medication.

Additional information

Weight 31.0 g
Marketed by


Dosage form




Therapeutic use